Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer. [electronic resource]
Producer: 20200420Description: 118775 p. digitalISSN:- 1873-3476
- Antineoplastic Agents -- chemistry
- Caco-2 Cells
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cetuximab -- chemistry
- Chitosan -- chemistry
- Colonic Neoplasms -- drug therapy
- Curcumin -- chemistry
- Drug Delivery Systems -- methods
- Drug Liberation -- physiology
- G2 Phase Cell Cycle Checkpoints -- drug effects
- HCT116 Cells
- Humans
- Nanoparticles -- chemistry
- Pectins -- chemistry
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.